Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Cash from Operations (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Cash from Operations for 3 consecutive years, with 6247000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 155.34% to 6247000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 29553000.0 through Dec 2025, up 35.14% year-over-year, with the annual reading at 29553000.0 for FY2025, 35.14% up from the prior year.
  • Cash from Operations hit 6247000.0 in Q4 2025 for Camp4 Therapeutics, up from 11200000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 6247000.0 in Q4 2025 to a low of 14286000.0 in Q1 2025.
  • Historically, Cash from Operations has averaged 9655333.33 across 3 years, with a median of 11200000.0 in 2025.
  • Biggest YoY gain for Cash from Operations was 155.34% in 2025; the steepest drop was 28.21% in 2025.
  • Year by year, Cash from Operations stood at 11783000.0 in 2023, then increased by 4.2% to 11288000.0 in 2024, then soared by 155.34% to 6247000.0 in 2025.
  • Business Quant data shows Cash from Operations for CAMP at 6247000.0 in Q4 2025, 11200000.0 in Q3 2025, and 10314000.0 in Q2 2025.